| Literature DB >> 27589727 |
Julia Welzenbach1, Christiane Neuhoff2, Hanna Heidt3,4, Mehmet Ulas Cinar5,6, Christian Looft7, Karl Schellander8, Ernst Tholen9, Christine Große-Brinkhaus10.
Abstract
The aim of this study was to integrate multi omics data to characterize underlying functional pathways and candidate genes for drip loss in pigs. The consideration of different omics levels allows elucidating the black box of phenotype expression. Metabolite and protein profiling was applied in Musculus longissimus dorsi samples of 97 Duroc × Pietrain pigs. In total, 126 and 35 annotated metabolites and proteins were quantified, respectively. In addition, all animals were genotyped with the porcine 60 k Illumina beadchip. An enrichment analysis resulted in 10 pathways, amongst others, sphingolipid metabolism and glycolysis/gluconeogenesis, with significant influence on drip loss. Drip loss and 22 metabolic components were analyzed as intermediate phenotypes within a genome-wide association study (GWAS). We detected significantly associated genetic markers and candidate genes for drip loss and for most of the metabolic components. On chromosome 18, a region with promising candidate genes was identified based on SNPs associated with drip loss, the protein "phosphoglycerate mutase 2" and the metabolite glycine. We hypothesize that association studies based on intermediate phenotypes are able to provide comprehensive insights in the genetic variation of genes directly involved in the metabolism of performance traits. In this way, the analyses contribute to identify reliable candidate genes.Entities:
Keywords: candidate genes; drip loss; enrichment analysis; genome-wide association study (GWAS); metabolomics; pork quality; proteomics
Mesh:
Substances:
Year: 2016 PMID: 27589727 PMCID: PMC5037705 DOI: 10.3390/ijms17091426
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Descriptive statistics and phenotypic correlations between drip loss and metabotypes.
| Traits | Mean ± SD 1 | Min 2 | Max 3 | Correlation to Drip Loss 4 |
|---|---|---|---|---|
| drip loss, % | 1.97 ± 1.40 | 0.40 | 5.30 | 1 |
| pH1 | 6.53 ± 0.22 | 5.89 | 6.94 | −0.31 ** |
| pH24 | 5.52 ± 1.12 | 5.32 | 6.06 | −0.35 *** |
| 26,454.10 ± 17,829.55 | 13.47 | 88,251.64 | −0.20 * | |
| 5600.37 ± 4985.98 | −10.77 | 32,935.16 | −0.19 | |
| 27,407.08 ± 20,231.70 | 809.35 | 114,192.30 | −0.11 | |
| 1754.68 ± 1526.65 | 32.13 | 7802.84 | −0.21 * | |
| pyruvic acid | 4.32 × 10−2 ± 3.62 × 10−2 | 6.16 × 10−3 | 2.11 × 10−1 | 0.22 * |
| lactic acid | 6.49 × 10−1 ± 3.28 × 10−1 | 1.88 × 10−1 | 1.64 | 0.08 |
| glucose | 9.02 × 10−3 ± 1.32 × 10−2 | 1.21 × 10−4 | 8.41 × 10−2 | 0.19 |
| phosphoenol pyruvate | 5.59 × 10−2 ± 8.95 × 10−2 | 1.80 × 10−3 | 0.53 | 0.13 |
| glycerone-p | 1.86 ± 1.10 | 2.48 × 10−1 | 5.85 | 0.07 |
| DG3P | 2.56 × 10−1 ± 4.09 × 10−1 | 2.61 × 10−3 | 2.61 | 0.14 |
| fumaric acid | 2.67 × 10−3 ± 1.25 × 10−3 | 5.50 × 10−4 | 7.23 × 10−3 | 0.12 |
| succinic acid | 1.38 × 10−2 ± 5.02 × 10−3 | 3.23 × 10−3 | 3.23 × 10−2 | −0.02 |
| malic acid | 6.03 × 10−3 ± 2.92 × 10−3 | 8.85 × 10−4 | 1.64 × 10−2 | 0.11 |
| methylglyoxal | 9.62 × 10−3 ± 5.44 × 10−3 | 2.61 × 10−4 | 2.89 × 10−2 | 0.22 * |
| glycine | 8.59 × 10−2 ± 2.39 × 10−2 | 4.84 × 10−2 | 1.62 × 10−1 | 0.11 |
| hydroxypyruvic acid | 1.06 × 10−2 ± 6.81 × 10−3 | 1.76 × 10−3 | 4.98 × 10−2 | 0.02 |
| F6P | 2.17 × 10−2 ± 3.43 × 10−2 | 2.91 × 10−4 | 2.25 × 10−1 | 0.12 |
| serine | 6.04 × 10−3 ± 2.99 × 10−3 | 1.76 × 10−3 | 2.15 × 10−2 | −0.01 |
| glycerone | 1.41 × 10−1 ± 8.36 × 10−2 | 2.17 × 10−2 | 4.37 × 10−1 | 0.20 |
| ceramide | 1.68 × 10−4 ± 1.24 × 10−3 | 2.33 × 10−6 | 6.59 × 10−4 | 0.05 |
| glucosylceramide | 2.46 × 10−3 ± 4.72 × 10−3 | 1.69 × 10−4 | 2.72 × 10−2 | 0.21 * |
| phosphoethanolamine | 8.57 × 10−4 ± 5.01 × 10−4 | 2.28 × 10−4 | 3.52 × 10−3 | 0.12 |
Drip loss measured in Musculus longissimus dorsi (LD) 24 h post-mortem (p.m.); pH measured 1 h post-mortem (p.m.) (pH1) and 24 h p.m. (pH24) in LD; 1 mean and standard deviation (SD); 2 minimum (Min); 3 maximum (Max); 4 calculation of correlation coefficients based on residuals; Mean, SD, Min and Max of proteins are based on signal dependent intensities of ion fragments (in mass) relative to time, so-called selection reaction monitoring (SRM) intensities; The units of the metabolite profiles are based on mass intensities, recorded by GC-MS and LC-QTOF/MS, normalized to an internal standard; * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001; glycerone-p = dihydroxyacetone phosphate; PGAM2 = phosphoglycerate mutase 2 (muscle); PKM = pyruvate kinase (muscle); FBPase = fructose-1,6-bisphosphatase 2; TPI1 = triose phosphate isomerase 1; DG3P = d-glycerate-3-phosphate; F6P = fructose-6-phosphate; bold: proteins.
Significant KEGG pathways for drip loss.
| Pathway | KEGG-ID | Involved Metabolites and Proteins | |
|---|---|---|---|
| Sphingolipid metabolism | 00600 | 0.014 | ceramide, glucosylceramide, phosphoethanolamine, serine |
| Type II diabetes mellitus | 04930 | 0.018 | pyruvic acid, glucose, |
| Methane metabolism | 00680 | 0.020 | glycine, pyruvic acid, hydroxypyruvic acid, F6P, malic acid, serine, phosphoenol pyruvate, glycerone-p, glycerone, DG3P |
| Renal cell carcinoma | 05211 | 0.027 | fumaric acid, malic acid |
| Insulin secretion | 04911 | 0.043 | pyruvic acid, glucose |
| Meiosis yeast | 04113 | 0.045 | glucose |
| NAFLD | 04932 | 0.045 | glucose |
| Glycolysis/Gluconeogenesis | 00010 | 0.045 | pyruvic acid, lactic acid, glucose, phosphoenol pyruvate, glycerone-p, DG3P, |
| Pyruvate metabolism | 00620 | 0.053 | fumaric acid, pyruvic acid, succinic acid, lactic acid, malic acid, phosphoenol pyruvate, methylglyoxal, |
| Steptomycin biosynthesis | 00521 | 0.056 | glucose, myo-inositol |
The enrichment analysis was performed based on 129 metabolites and 35 proteins. Overrepresentation of metabolic pathways defined by the KEGG database regarding to drip loss was tested using Wilcoxon’s rank sum test; * The pathway was considered significant if p ≤ 0.05; Kyoto Encyclopaedia of Genes and Genomes (KEGG)-ID = KEGG pathway ID; NAFLD = Non-alcoholic Fatty liver disease; glycerone-p = dihydroxyacetone phosphate; PGAM2 = phosphoglycerate mutase 2 (muscle); PKM = pyruvate kinase (muscle); FBPase = fructose-1,6-bisphosphatase 2; TPI1 = triosephosphate isomerase 1; DG3P = d-glycerate-3-phosphate; F6P = fructose-6-phosphate; bold: proteins.
Results of association analyses.
| Trait | ID | PC 1 | λ 2 | Number of Significant SNP/QTL per Porcine Chromosome 3 | ∑SNP 4 | Min | Min | Max | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 6 | 7 | 8 | 10 | 13 | 14 | 16 | 17 | 18 | ||||||||
| drip loss | - | 10 | 1.007 | 4/4 | 74/20 | 78 # | 6.58 | 6.26 | 8.8 | |||||||||||
| 100158154 | 10 | 1 | 33/13 | 33 # | 10.7 | 7.84 | 14.3 | |||||||||||||
| 100188980 | 10 | 1.06 | 18/7 | 18 # | 19.9 | 8.67 | 13.9 | |||||||||||||
| 100134828 | 10 | 1 | 5/1 | 244/92 | 118 *, 131 # | 1.98 | 2.27 | 16.6 | ||||||||||||
| glucose | C00031 | 10 | 1 | 2/2 | 2 # | 5.86 | 8.80 | 15.3 | ||||||||||||
| glycerone-p | C00111 | 10 | 1.046 | 4/1 | 7/4 | 23/10 | 34 # | 2.35 | 5.07 | 17.3 | ||||||||||
| DG3P | C00197 | 10 | 1 | 10/5 | 2 *, 8 # | 1.50 | 2.19 | 17.3 | ||||||||||||
| succinic acid | C00042 | 2 | 1.03 | 179/64 | 122 *, 57 # | 29.3 | 5.07 | 13.3 | ||||||||||||
| glycine | C00037 | 10 | 1.05 | 97/41 | 2/2 | 133/48 | 102 *, 130 # | 3.39 | 4.67 | 17.1 | ||||||||||
| hydroxyl-pyruvic acid | C00168 | 10 | 1 | 104/28 | 76 *, 28 # | 3.44 | 1.88 | 16.1 | ||||||||||||
| F6P | C00085 | 10 | 1 | 12/9 | 12 # | 8.00 | 7.69 | 14.8 | ||||||||||||
| glycerone | C00184 | 10 | 1 | 7/4 | 7 # | 7.95 | 8.56 | 14.8 | ||||||||||||
| ceramide | C00195 | 4 | 1.006 | 20/8 | 20 # | 11.8 | 8.02 | 14.4 | ||||||||||||
| glucosyl-ceramide | C01190 | 10 | 1.012 | 3/3 | 1/1 | 4 # | 1.59 | 6.64 | 17.4 | |||||||||||
| phosphor-ethanolamine | C00346 | 10 | 1.08 | 15/8 | 11 *, 4 # | 15.4 | 3.81 | 14.5 | ||||||||||||
| ∑SNP/QTL excluding double counting | 7/4 | 97/41 | 1/1 | 33/13 | 15/8 | 13/10 | 27/12 | 2/2 | 5/1 | 195/80 | 4/4 | 275/100 | 197/54 | |||||||
| ∑overlapping SNP/QTL 8 | 1/1 | 95/16 | 2/7 | 28/21 | ||||||||||||||||
Drip loss measured in Musculus longissimus dorsi (LD) 24 h post-mortem (p.m.) (%); 1 number of principal components (PCs) considered in genome-wide association (GWA) studies; 2 λ = inflation factor; 3 number of chromosome-wide significant associated SNPs and QTL per traits and chromosome (at least q ≤ 0.1); 4 sum of significant associated SNPs per traits (* q ≤ 0.05; # q ≤ 0.1); 5 minimal empirical p-value (times 10−5); 6 minimal q-value (times 10−5), based in the false discovery rate (FDR) concept; 7 maximal proportion of explained variance (%); 8 sum of overlapping SNP/QTL with meaning for two traits; ID = Entrez gene ID for proteins or KEGG compound ID for metabolites; glycerone-p = dihydroxyacetone phosphate; PGAM2 = phosphoglycerate mutase 2 (muscle); PKM = pyruvate kinase (muscle); FBPase = fructose-1,6-bisphosphatase 2; DG3P = d-glycerate-3-phosphate; F6P = fructose-6-phosphate; bold: proteins.
Figure 1Overlapping SNPs at Sus scrofa chromosomes (SSC) 14, 17 and 18. GWAS procedures resulted in varying numbers of significant SNP (q ≤ 0.1) per trait. On some chromosomes there are overlapping SNPs with meaning for two traits. Drip loss measured in Musculus longissimus dorsi (LD) 24 h post-mortem (p.m.); Glycerone-p = dihydroxyacetone phosphate; PGAM2 = phosphoglycerate mutase 2 (muscle); FBPase = fructose-1,6-bisphosphatase 2; DG3P = d-glycerate-3-phosphate.
Functional annotation of significant SNPs associated with drip loss and metabolic traits.
| SSC 1 | 1 | 2 | 3 | 4 | 6 | 7 | 8 | 10 | 13 | 14 | 16 | 17 | 18 | ∑ |
| Genes 2 | 30 | 148 | 4 | 65 | 31 | 48 | 70 | 15 | 12 | 375 | 13 | 367 | 252 | 1430 |
| SNP 3 | 2/7 | 30/97 | -/1 | 15/33 | 2/15 | -/13 | 2/27 | 1/2 | 5/5 | 83/195 | -/4 | 54/275 | 63/197 | 257/871 |
1 Sus scrofa chromosomes; 2 number of genes that are located in a distance of ≤1 Mb to the significant SNPs revealed by GWAS; 3 number of intronic SNPs in relation to the total number of significant SNPs per chromosome (without double counting of overlapping SNPs).
Annotation of most promising SNPs for drip loss and associated metabolic components.
| SSC 1 | Trait | Gene 2 | SNP 3 | Position 4 | Mut 5 | MAF 6 | eEff (se) 7 | Chi2 | Emp. | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | glycerone-p | INRA0001633 | 35387799 | G/A | 0.47 | −4.00 × 10−2 | (1.00 × 10−2) | 18.68 | 0.22 | 5.07 | 17.35 | |
| glucosylceramide | ALGA0007238 | 204522804 | C/A | 0.47 | −9.32 × 10−5 | (2.15 × 10−5) | 18.80 | 0.16 | 6.64 | 17.44 | ||
| 4 | INRA0016801 | 123080603 | G/A | 0.27 | −9.21 × 102 | (2.57 × 102) | 12.88 | 3.32 | 7.84 | 13.21 | ||
| ASGA0023322 | 139599066 | G/A | 0.38 | −6.43 × 102 | (1.77 × 102) | 13.26 | 2.71 | 7.84 | 12.72 | |||
| M1GA0006779 | 139861416 | C/A | 0.43 | 6.76 × 102 | (1.89 × 102) | 12.88 | 3.32 | 7.84 | 12.40 | |||
| ALGA0029718 | 142789911 | A/G | 0.46 | 8.52 × 102 | (2.20 × 102) | 15.01 | 1.07 | 7.84 | 14.29 | |||
| ALGA0029732 | 142739989 | G/A | 0.39 | 9.23 × 102 | (2.49 × 102) | 13.70 | 2.14 | 7.84 | 13.09 | |||
| ALGA0029741 | 142730172 | G/A | 0.46 | 8.13 × 102 | (2.15 × 102) | 14.20 | 1.64 | 7.84 | 13.50 | |||
| ASGA0023626 | 143204232 | A/G | 0.40 | 9.05 × 102 | (2.43 × 102) | 13.86 | 1.97 | 7.84 | 13.21 | |||
| INRA0018033 | 143449789 | A/G | 0.40 | 9.05 × 102 | (2.43 × 102) | 13.86 | 1.97 | 7.84 | 10.77 | |||
| 6 | phosphor-ethanolamine | DRGA0006746 | 118055075 | G/A | 0.26 | 2.91 × 10−5 | (7.54 × 10−6) | 14.93 | 1.76 | 3.81 | 14.36 | |
| INRA0022204 | 120225026 | C/A | 0.26 | 2.91 × 10−5 | (7.54 × 10−6) | 14.93 | 1.76 | 3.81 | 14.36 | |||
| 10 | glycine | MARC0098464 | 18065301 | C/A | 0.34 | −1.55 × 10−3 | (3.80 × 10−4) | 16.56 | 0.69 | 5.11 | 15.69 | |
| 13 | MARC0019610 | 210504370 | G/A | 0.49 | 6.54 × 102 | (1.70 × 102) | 14.71 | 1.25 | 8.64 | 13.92 | ||
| MARC0005075 | 210516458 | A/C | 0.49 | 6.54 × 102 | (1.70 × 102) | 14.71 | 1.25 | 8.64 | 13.92 | |||
| ASGA0089689 | 210516937 | G/A | 0.49 | 6.54 × 102 | (1.70 × 102) | 14.71 | 1.25 | 8.64 | 13.92 | |||
| ASGA0089950 | 210531047 | A/G | 0.49 | 6.54 × 102 | (1.70 × 102) | 14.71 | 1.25 | 8.64 | 13.92 | |||
| ASGA0097399 | 210534054 | G/C | 0.49 | 6.54 × 102 | (1.70 × 102) | 14.71 | 1.25 | 8.64 | 13.92 | |||
| 14 | succinic acid | MARC0033238 | 68550413 | G/A | 0.52 | 1.69 × 10−4 | (4.59 × 10−5) | 13.60 | 2.93 | 2.82 | 13.26 | |
| ASGA0064107 | 68604989 | A/G | 0.52 | 1.69 × 10−4 | (4.59 × 10−5) | 13.60 | 2.93 | 2.82 | 13.26 | |||
| ALGA0078235 | 66284845 | G/A | 0.52 | 1.69 × 10−4 | (4.59 × 10−4) | 13.60 | 2.93 | 2.82 | 13.26 | |||
| ALGA0078240 | 66320818 | A/C | 0.52 | 1.69 × 10−4 | (4.59 × 10−5) | 13.60 | 2.93 | 2.82 | 13.26 | |||
| ALGA0078243 | 66332408 | G/A | 0.52 | 1.69 × 10−4 | (4.59 × 10−5) | 13.60 | 2.93 | 2.82 | 13.26 | |||
| 17 | DG3P | MARC0016232 | 50694545 | A/G | 0.41 | −1.96 × 10−2 | (5.27 × 10−3) | 13.88 | 1.94 | 6.53 | 13.49 | |
| H3GA0049968 | 65818274 | A/G | 0.48 | 1.71 × 10−2 | (4.79 × 10−3) | 12.78 | 3.51 | 6.53 | 12.55 | |||
| 18 | PGAM2 | ALGA0107449 | 12234417 | G/A | 0.41 | 1.88 × 102 | (4.90 × 101) | 14.79 | 1.99 | 8.67 | 13.98 | |
| drip loss | ALGA0097051 | 12921061 | A/G | 0.25 | −7.81 × 10−2 | (2.49 × 10−2) | 9.87 | 17.6 | 6.26 | 5.61 | ||
| glycine | ASGA0079000 | 15942579 | A/G | 0.31 | −1.63 × 10−3 | (4.07 × 10−4) | 16.06 | 0.90 | 1.66 | 15.28 | ||
| drip loss | ALGA0097170 | 15969549 | G/A | 0.45 | −4.34 × 10−2 | (1.38 × 10−2) | 9.87 | 17.5 | 6.26 | 5.61 | ||
| DIAS0001125 | 16179365 | G/A | 0.48 | 4.15 × 10−2 | (1.31 × 10−2) | 10.08 | 15.6 | 6.26 | 5.72 | |||
| H3GA0050495 | 20338092 | A/G | 0.28 | −7.16 × 10−2 | (2.14 × 10−2) | 11.21 | 8.54 | 6.26 | 6.32 | |||
| ASGA0079098 | 20520014 | G/A | 0.30 | −7.16 × 10−2 | (2.14 × 10−2) | 11.21 | 8.54 | 6.26 | 6.32 | |||
| ASGA0100894 | 51012467 | C/A | 0.42 | 1.89 × 102 | (5.35 × 101) | 12.53 | 6.18 | 8.67 | 12.10 | |||
The SNP order complies with number of chromosomes and position on the chromosome; Selection of promising SNPs based on the criteria, that they are (1) chromosome-wide significant (at least p < 0.1); (2) within the “Top 10” significant SNPs per metabolic trait or “Top 25” for drip loss and (3) located within an annotated gene; 1 Sus scrofa chromosomes (SSC); 2 The declaration of gene symbols can be obtained from Ensembl or http://www.ncbi.nlm.nih.gov/gene; 3 None of the SNPs is located in an exon region of the regarding candidate gene; 4 position in BP (base pairs); 5 mutation (Mut); 6 minor allele frequency (MAF); 7 eEff = substitution effect and se = standard error; 8 empirical p-value, times 10−4; 9 q-value (based on the false discovery rate (FDR) concept), times 10−2; 10 Var = proportion of the explained variation [%]; glycerone-p = dihydroxyacetone phosphate; PGAM2 = phosphoglycerate mutase 2 (muscle); PKM = pyruvate kinase (muscle); FBPase = fructose-1,6-bisphosphatase 2; DG3P = d-glycerate-3-phosphate; bold: proteins.
“Top 25” significant SNPs identified for drip loss and potential candidate genes.
| SNP | SSC 1 | Position 2 | Mut 3 | MAF 4 | eEff (se) 5 | Chi2 | Emp. | Located within a Gene 9 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALGA0089069 | 16 | 11629284 | C/A | 0.08 | 2.26 × 10−1 | (5.65 × 10−2) | 16.05 | 6.58 × 10−5 | 7.02 × 10−2 | 8.82 | × |
| 2 | CASI0008411 | 16 | 23115634 | G/A | 0.10 | 1.89 × 10−1 | (4.86 × 10−2) | 15.03 | 1.12 × 10−4 | 7.02 × 10−2 | 8.30 | × |
| 3 | MARC0097282 | 16 | 10946289 | G/A | 0.33 | 7.45 × 10−2 | (1.95 × 10−2) | 14.65 | 1.38 × 10−4 | 7.02 × 10−2 | 8.15 | × |
| 4 | ASGA0072217 | 16 | 9183890 | A/G | 0.34 | 7.25 × 10−2 | (1.93 × 10−2) | 14.16 | 1.78 × 10−4 | 7.02 × 10−2 | 7.90 | × |
| 5 | ALGA0111681 | 18 | 6026724 | G/A | 0.15 | 1.35 × 10−1 | (3.78 × 10−2) | 12.71 | 3.83 × 10−4 | 6.26 × 10−2 | 7.11 | × |
| 6 | ASGA0104044 | 18 | 4388048 | A/C | 0.15 | 1.27 × 10−1 | (3.61 × 10−2) | 12.34 | 4.68 × 10−4 | 6.26 × 10−2 | 6.92 | × |
| 7 | MARC0003904 | 18 | 12368984 | G/A | 0.35 | −6.37 × 10−2 | (1.90 × 10−2) | 11.23 | 8.45 × 10−4 | 6.26 × 10−2 | 6.33 | × |
| 8 | ASGA0078921 | 18 | 13751595 | G/A | 0.29 | −7.46 × 10−2 | (2.23 × 10−2) | 11.21 | 8.53 × 10−4 | 6.26 × 10−2 | 6.33 | × |
| 9 | H3GA0050495 | 18 | 20338092 | G/A | 0.30 | −7.16 × 10−2 | (2.14 × 10−2) | 11.21 | 8.54 × 10−4 | 6.26 × 10−2 | 6.33 | |
| 10 | ASGA0079098 | 18 | 20520014 | A/G | 0.30 | −7.16 × 10−2 | (2.14 × 10−2) | 11.21 | 8.54 × 10−4 | 6.26 × 10−2 | 6.33 | |
| 11 | ALGA0105391 | 18 | 5935981 | G/A | 0.31 | 6.69 × 10−2 | (2.07 × 10−2) | 10.48 | 1.26 × 10−3 | 6.26 × 10−2 | 5.94 | × |
| 12 | INRA0055248 | 18 | 13959002 | G/A | 0.47 | −4.24 × 10−2 | (1.31 × 10−2) | 10.40 | 1.32 × 10−3 | 6.26 × 10−2 | 5.90 | × |
| 13 | MARC0036783 | 18 | 16113241 | A/G | 0.47 | −4.23 × 10−2 | (1.32 × 10−2) | 10.27 | 1.41 × 10−3 | 6.26 × 10−2 | 5.82 | × |
| 14 | ASGA0098607 | 18 | 3614625 | A/G | 0.38 | −5.35 × 10−2 | (1.68 × 10−2) | 10.20 | 1.47 × 10−3 | 6.26 × 10−2 | 5.79 | × |
| 15 | ALGA0104874 | 18 | 3620895 | A/G | 0.38 | −5.35 × 10−2 | (1.68 × 10−2) | 10.20 | 1.47 × 10−3 | 6.26 × 10−2 | 5.79 | × |
| 16 | ASGA0088995 | 18 | 3741888 | G/G | 0.38 | −5.35 × 10−2 | (1.68 × 10−2) | 10.20 | 1.47 × 10−3 | 6.26 × 10−2 | 5.79 | × |
| 17 | H3GA0050278 | 18 | 3808173 | A/G | 0.38 | −5.35 × 10−2 | (1.68 × 10−2) | 10.20 | 1.47 × 10−3 | 6.26 × 10−2 | 5.79 | × |
| 18 | ASGA0078689 | 18 | 3833808 | G/A | 0.38 | −5.35 × 10−2 | (1.68 × 10−2) | 10.20 | 1.47 × 10−3 | 6.26 × 10−2 | 5.79 | × |
| 19 | DIAS0001125 | 18 | 16179365 | G/A | 0.48 | 4.15 × 10−2 | (1.31 × 10−2) | 10.08 | 1.56 × 10−3 | 6.26 × 10−2 | 5.72 | |
| 20 | ALGA0097186 | 18 | 16444813 | G/A | 0.47 | 4.20 × 10−2 | (1.32 × 10−2) | 10.06 | 1.58 × 10−3 | 6.26 × 10−2 | 5.71 | × |
| 21 | ALGA0096804 | 18 | 3907848 | G/A | 032 | 5.58 × 10−2 | (1.77 × 10−2) | 10.01 | 1.63 × 10−3 | 6.26 × 10−2 | 5.69 | × |
| 22 | ALGA0116114 | 18 | 15594213 | A/G | 0.46 | −4.22 × 10−2 | (1.34 × 10−2) | 9.94 | 1.69 × 10−3 | 6.26 × 10−2 | 5.65 | × |
| 23 | ALGA0097170 | 18 | 15969549 | G/A | 0.45 | −4.34 × 10−2 | (1.38 × 10−2) | 9.88 | 1.75 × 10−3 | 6.26 × 10−2 | 5.62 | |
| 24 | ALGA0097051 | 18 | 12921061 | A/G | 0.25 | −7.81 × 10−2 | (2.49 × 10−2) | 9.87 | 1.76 × 10−3 | 6.26 × 10−2 | 5.61 | |
| 25 | ALGA0097067 | 18 | 13674866 | A/G | 0.25 | −7.81 × 10−2 | (2.49 × 10−2) | 9.87 | 1.76 × 10−3 | 6.26 × 10−2 | 5.61 | × |
The SNP order complies with raising p-value; 1 Sus scrofa chromosomes (SSC); 2 position in base pairs (BP); 3 mutation (Mut); 4 minor allele frequency (MAF); 5 substitution effect and standard error (se); 6 empirical p-value and significant thresholds, 7 q-value (based in the false discovery rate (FDR) concept); 8 Var = proportion of the explained variation [%]; 9 The declaration of gene symbols can be obtained from Ensembl or http://www.ncbi.nlm.nih.gov/gene, “×”, SNP is not located within a gene, none of the SNPs is located in an exon region of the regarding gene.
Figure 2Chromosome-wide Manhattan plot of Sus scrofa chromosome (SSC) 18. Drip loss measured in Musculus longissimus dorsi (LD) 24 h post-mortem (p.m.); PGAM2 = phosphoglycerate mutase 2; the declaration of gene symbols (in black boxes) can be obtained from Ensembl or http://www.ncbi.nlm.nih.gov/genegenes.
Figure 3Region on Sus scrofa chromosome (SSC) 18 with potential candidate genes for drip loss and associated metabolic traits phosphoglycerate mutase 2 and glycine. Drip loss measured in Musculus longissimus dorsi (LD) 24 h post-mortem (p.m.); PGAM2 = phosphoglycerate mutase 2; fat solid arrows = direct relation between SNPs and drip loss; thin solid arrows = indirect relation between SNPs and drip loss via metabolite glycine; dotted arrow = indirect relation between SNPs and drip loss via protein PGAM2; genes in boxes: CREB3L2 = cAMP responsive element binding protein 3 like 2; PTN = Sus scrofa pleiotropic factor beta; LRGUK = leucine-rich repeats and guanylate kinase domain containing; EXOC4 = exocyst complex component 4.